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he budding yeast Cdc48p and its mammalian homo-
logue p97 are involved in many important cellular
 
activities. Because previous 
 
cdc48
 
 mutants have
exclusive G2/M arrest, Cdc48p was thought to play an
essential role only during mitosis. We found that Cdc48p is
required for the execution of Start (a yeast cell cycle com-
mitment point equivalent to the restriction point in mam-
malian cells) in both a normal mitotic cell cycle and cell
T
 
cycle reentry after mating pheromone withdrawal through
degradation of the G1–cyclin-dependent kinase inhibitor
Far1p. Our work is the ﬁrst to uncover novel roles of
Cdc48p as a critical cell cycle regulator in G1, and to shed
new light on cell cycle regulation of Far1p, which is the ﬁrst
cyclin-dependent kinase inhibitor shown to be a substrate
of an essential proteolysis event mediated by Cdc48p.
 
Introduction
 
Cdc48p/p97 homologues (p97 is also termed VCP [valosin-
containing protein]) belong to the AAA (ATPase associated
with a variety of cellular activities) superfamily. Cdc48p/p97
has been shown to participate in a variety of cellular pro-
cesses including: mitosis (Moir et al., 1982; Frohlich et al.,
1991), spindle pole organization (Frohlich et al., 1991),
homotypic membrane fusion (Latterich et al., 1995; Kondo
et al., 1997), endoplasmic reticulum–associated protein deg-
radation (Braun et al., 2002; Jarosch et al., 2002; Rabinovich
et al., 2002), transcription factor processing (Hoppe et al.,
2000; Hitchcock et al., 2001; Rape et al., 2001), and
ubiquitin–proteasome proteolysis pathways (Ghislain et al.,
1996; Dai et al., 1998; Dai and Li, 2001).
Ubiquitin-mediated proteolysis plays critical roles in the
cell cycle by regulating cyclin-dependent kinase
 
 (
 
CDK)
activities through degradation of CDK activators or inhibitors,
thus promoting cell cycle transitions. After target proteins
are multi-ubiquitinated, they are transported to the 26S
proteasome for degradation. Recently, the crucial role of a
chaperone-like Cdc48–Ufd1–Npl4 complex has been iden-
tified in the recognition and transport of polyubiquitin-
tagged proteins, bringing them to the 26S proteasome for
degradation (Meyer et al., 2000, 2002; Dai and Li, 2001; Ye
et al., 2001). These studies suggest that Cdc48p regulates
many cellular processes by this mechanism.
Besides mitosis, the G1 phase of the cell cycle is also con-
trolled in part by ubiquitin-mediated proteolysis. One of the
critical control points in G1 phase is the Start in yeast,
which is equivalent to the restriction point in mammalian
cells. After yeast cells have passed through Start, they not
only initiate DNA replication but also form buds and duplicate
their spindle pole. Activation of Cdc28 protein kinase by
G1-specific cyclins is necessary for all of these Start events.
However, Cdc48p has not been implicated in G1 control.
The previous conditional 
 
cdc48
 
 mutants are quite “leaky,”
as indicated by several cell doublings before eventual G2/M
arrest at the restrictive temperatures (Moir et al., 1982;
Frohlich et al., 1991), which has led to the idea that Cdc48p
plays an essential role only during mitosis. By using a “tight”
temperature-sensitive degron (td) mutant in 
 
CDC48
 
, we
found that Cdc48p is required for Start in G1 phase, as well
as for mitosis. Furthermore, Cdc48p is essential for Start
execution in both mitotic cell cycle and cell cycle reentry after
mating pheromone removal; this function is achieved
through degradation of the G1-CDK inhibitor Far1p.
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Hong Kong, China. Tel.: 852-23587296. Fax.: 852-23581552. email:
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Abbreviations used in this paper: CDK, cyclin-dependent kinase; td,
temperature-sensitive degron; coIP, coimmunoprecipitation; IP, immuno-
precipitation.T
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Results and discussion
 
To study the functions of Cdc48p in the cell cycle, we con-
structed a 
 
cdc48-td
 
 mutant in a 
 
GAL-UBR1
 
 strain in which
 
UBR1
 
, the gene encoding the degron recognition factor, can
be induced by galactose for efficient degradation of degron-
tagged proteins at 37
 
 
 
C (Labib et al., 2000). The Cdc48-td
protein in 
 
cdc48-td
 
 cells could be mostly degraded within
1 h at 37
 
 
 
C (unpublished data). The wild-type 
 
CDC48
 
 gene
on a plasmid could completely rescue the 
 
cdc48-td
 
 mutant
(unpublished data); strains complemented in this way were
used as wild-type controls. 
The wild-type control and 
 
cdc48-td
 
 strains were first syn-
chronized in G1 phase with the mating pheromone 
 
 
 
 factor,
and each culture was split into two halves: one half was left at
the permissive temperature of 25
 
 
 
C as the control, while the
other half was induced to degrade the Cdc48-td protein in
 
cdc48-td
 
 cells at 37
 
 
 
C. Next, cells in the two cultures of each
strain were released from 
 
 
 
 factor arrest into fresh medium at
25
 
 
 
C (Fig. 1 A) or 37
 
 
 
C (Fig. 1 B), respectively, and cell cycle
progressions were monitored by flow cytometry and budding
index counting at various time points after release. Wild-type
cells at both 25
 
 
 
C and 37
 
 
 
C and 
 
cdc48-td
 
 cells at 25
 
 
 
C
showed normal kinetics of bud formation and S phase entry
and progression (Fig. 1). In contrast, most 
 
cdc48-td
 
 cells were
unable to bud or enter S phase at 37
 
 
 
C (Fig. 1). Because bud
formation and S phase entry are two independent cell cycle
events that initiate simultaneously at the G1/S transition after
cells have traversed Start, our data suggest that Cdc48p is re-
quired for the execution of Start.
In response to 
 
 
 
 factor in G1, the expression of Cln1p-
Cln3p (the G1 cyclins) and activity of Cdc28p-Cln (the G1-
CDK) are inhibited, and cells arrest at Start. Reentry into
the cell cycle after 
 
 
 
 factor removal is achieved by recovery
of the Cdc28p-Cln activities. Therefore, it is possible that
the failure of 
 
cdc48-td
 
 mutant cells to traverse Start at 37
 
 
 
C
after 
 
 
 
 factor withdrawal was due to the inability of the cells
to recover the G1-CDK activities. To test this possibility, we
blocked wild-type and 
 
cdc48-td
 
 cells in G1 with 
 
 
 
 factor, in-
duced Cdc48-td proteolysis at 37
 
 
 
C, and then released the
cells into fresh medium at 37
 
 
 
C. Cells were harvested at dif-
ferent time points after release; Cdc28p and associated pro-
teins were precipitated by p13
 
Suc1
 
 beads (p13 is a fission
Figure 1. cdc48-td cells are defective for budding and S phase entry. 
Wild-type (CDC48) and cdc48-td cells were arrested in G1 with   
factor at 25 C in glucose medium, and one half of culture remained 
in the same medium at 25 C for 2 h, while the other half was trans-
ferred into galactose medium containing   factor at 25 C to induce 
UBR1 for 1 h and then shifted to 37 C for 1 h to degrade the Cdc48-td 
protein. Next, cells were released from   factor arrest into glucose 
medium at 25 C (A) or galactose medium at 37 C (B), respectively. 
Aliquots of cells were collected at various time points after release. 
Cell cycle progressions of the cells were monitored by flow cytometry 
and budding index counting (% Budded, percentages of budded cells 
in the population).
Figure 2. cdc48-td cells are defective for activation of Cdc28p-Cln 
kinase and degradation of Far1p. (A) Wild-type (CDC48) and cdc48-td 
cells were synchronized with   factor at 25 C in raffinose medium. 
Galactose was added to induce UBR1 at 25 C for 1 h, and the cells 
were shifted to 37 C for 1 h to degrade the Cdc48-td protein. The 
cells were released into fresh galactose medium at 37 C for 1 h and 
harvested at 20-min intervals. After precipitation with p13
Suc1 beads, 
the kinase activities and amounts of precipitated Cdc28p were 
measured by histone H1 kinase assay and immunoblotting, respec-
tively. Cell cycle progressions were monitored by flow cytometry. 
(B–D) Similar experiments to those in A were performed with 
CLN2-Myc (B) or FAR1-Myc cells (C and D) in CDC48 and cdc48-td 
backgrounds, and anti-Myc immunoblotting for whole cell extracts 
(B and C), or antiubiquitin immunoblotting for anti-Myc immunopre-
cipitates (D) was performed. Orc3p served as the gel loading control. 
(E) Extracts from FAR1-Myc–tagged and untagged strains were 
immunoprecipitated with anti-Myc, and whole cell extract and im-
munoprecipitates were immunoblotted with antiubiquitin.T
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yeast CDK-binding protein that also binds the budding
yeast Cdc28p) from yeast cell extracts; and the Cdc28 kinase
activity was assayed using histone H1 as a substrate. In wild-
type cells, Cdc28 kinase activity was absent in 
 
 
 
 factor–
arrested cells (Fig. 2 A, 0 min) but gradually increased after re-
lease from the arrest, as expected. In contrast, no significant
kinase activity was detected in 
 
cdc48-td
 
 cells after release,
suggesting that recovery of the CDK activities after 
 
 
 
 factor
removal requires Cdc48p.
We examined the levels of Cln2p in total yeast cell extracts
in 
 
 
 
 factor arrest-and-release experiments with 
 
CLN2-Myc
 
strains. In wild-type cells, Cln2p was absent in 
 
 
 
 factor–
arrested cells and increased after release from the arrest, as ex-
pected (Fig. 2 B). However, in 
 
cdc48-td
 
 cells, Cln2p re-
mained at a low level after release. Together, the data shown
in Fig. 1 and Fig. 2 (A and B) suggest that Cdc48p is required
for recovery of 
 
CLN2
 
 expression, for Cdc28p-Cln kinase ac-
tivities, and for cell cycle reentry after 
 
 
 
 factor removal.
Because Cdc48p is known to be required for ubiquitin–
proteasome proteolysis pathways, we hypothesized that inhi-
bition of Cdc28-Cln kinase activities in 
 
cdc48-td
 
 resulted
from failure to degrade a Cdc28p-Cln inhibitor in 
 
cdc48-td
 
cells. One plausible candidate is Far1p (factor arrest), which
is required for G1 arrest through inhibition of 
 
CLN
 
 gene ex-
pression and of Cdc28-Cln kinase activities in response to 
 
 
 
factor (Chang and Herskowitz, 1990; McKinney et al., 1993;
Peter et al., 1993; Valdivieso et al., 1993; Peter and Hersko-
witz, 1994). Far1p is degraded through the ubiquitin–protea-
some pathway to allow cell cycle reentry after 
 
 
 
 factor with-
drawal (Henchoz et al., 1997; Blondel et al., 2000).
To test if the G1 arrest was attributable to failure to de-
grade Far1p in 
 
cdc48-td
 
 cells, we examined the levels of
Far1p in 
 
 
 
 factor arrest-and-release experiments with 
 
FAR1-
Myc
 
 strains. As expected, Far1p accumulated in both wild-
type and 
 
cdc48-td
 
 cells in the presence of 
 
 
 
 factor (Fig. 2 C,
0 min). Also as expected, the Far1p level decreased and ulti-
mately disappeared after wild-type cells were released from 
 
 
 
factor arrest (Fig. 2 C). However, Far1p was quite stable in
 
cdc48-td
 
 cells after release from 
 
 
 
 factor arrest (Fig. 2 C).
These results support our hypothesis that the inability to re-
enter the cell cycle resulted from failure of Far1p degrada-
tion in 
 
cdc48-td
 
 cells.
It has been shown that Cdc48p is responsible for bringing
ubiquitinated proteins to the 26S proteosome for degrada-
tion, but it is not required for ubiquitination of protein sub-
strates (Dai and Li, 2001; Hitchcock et al., 2001; Rape et
al., 2001; Ye et al., 2001). To determine if the role of
Cdc48p in Far1p degradation was also at a postubiquitina-
tion step, we used 
 
cdc48-td
 
 cells to check the ubiquitination
status of Far1p in 
 
 
 
 factor block-and-release experiments.
Far1-Myc was immunoprecipitated from yeast cell extracts
with an anti-Myc antibody, and precipitated proteins were
immunoblotted with an antiubiquitin antiserum. Far1-Myc
was found ubiquitinated in 
 
cdc48-td
 
 cells at 37
 
 
 
C, as evident
by the presence of smears (Fig. 2 D). We confirmed that the
signals attributed to Far1-Ub were indeed from Far1-Ub, as
smear signals could be detected by antiubiquitin immuno-
blotting in anti-Myc immunoprecipites from the 
 
FAR1-Myc
 
tagged, but not untagged, strains (Fig. 2 E). These results
suggest that Cdc48p is not required for ubiquitination of
Far1p, as in the case of other substrates whose degradation is
mediated through Cdc48p.
We have established that 
 
cdc48-td
 
 cells are defective for
Start due to failure of Far1p degradation. However, 
 
 
 
 factor
was used to synchronize cells in G1 in these experiments, as
in previous Far1p studies. To determine if Cdc48p was also
required for degradation of Far1p at Start in the mitotic cell
cycle, we examined cell cycle arrest phenotypes of 
 
cdc48-td
 
cells in experiments that did not use 
 
 
 
 factor for cell presyn-
chronization.
Asynchronous wild-type and 
 
cdc48-td
 
 cells were shifted to
37
 
 
 
C after induction of 
 
UBR1
 
 to degrade the Cdc48-td pro-
tein, or kept at 25
 
 
 
C as the control, and cell cycle distribu-
tions were examined by flow cytometry and bud index
counting. Judging from the DNA contents, 
 
cdc48-td
 
 cells
had both G1 and G2/M populations at both 25
 
 
 
and 37
 
 
 
C,
as did the wild-type cells (Fig. 3 A). However, only 
 
cdc48-td
 
cells at 37
 
 
 
C had most of their budded cells as large budded
compared with a more or less equal mixture of small- and
large-budded cells in wild-type cells at 25 and 37
 
 
 
C and
 
cdc48-td
 
 cells at 25
 
 
 
C (Fig. 3 A). This suggests that some
Figure 3. cdc48-td cells arrest in both G1 and G2/M at 37 C, and 
FAR1 deletion or CLN2 constitutive expression can overcome the 
G1 arrest. (A) Asynchronous wild-type (CDC48) and cdc48-td cells 
grown in glucose medium at 25 C were either transferred to galac-
tose medium at 25 C to induce UBR1 for 1 h and then shifted to 
37 C, or kept in glucose medium at 25 C. Nocodazole or   factor 
was added to aliquots of cells at 25 and 37 C, and samples were 
harvested for flow cytometry and budding index analysis 4 h later. 
% Budded (Large), percentages of budded cells and of large-budded 
cells (in parentheses, defined as those with bud size of at least 60% 
of the mother) among all budded cells. (B) After UBR1 induction, 
asynchronous CDC48/far1  and cdc48-td/far1  cells were shifted 
to 37 C in galactose medium with or without nocodazole, or kept 
in glucose medium at 25 C. Cells were analyzed as in A. (C) After 
UBR1 induction, asynchronous cdc48-td/CLN2 and cdc48-td/GAL-
CLN2 were shifted to 37 C in galactose medium or kept in glucose 
medium at 25 C. Cells were analyzed as in A.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
24 The Journal of Cell Biology | Volume 163, Number 1, 2003
cdc48-td cells arrested in G1 as unbudded cells with 1C
DNA, whereas others arrested in G2/M as large-budded
cells with 2C DNA at 37 C. To formally rule out the possi-
bility that cdc48-td cells might have no cell cycle arrest at
37 C, nocodazole or   factor was added to yeast cell cultures
just before they were shifted to 37 C (Fig. 3 A). As expected,
wild-type cells at both temperatures, and cdc48-td cells at
25 C, were able to traverse G1 and arrest in G2/M in the
nocodazole experiment, and to go through mitosis and arrest
in G1 in the   factor experiment. In contrast, at 37 C in the
presence of nocodazole or   factor, cdc48-td cells arrested in
both G1 and G2/M; i.e., they could not traverse either
G1 (in the nocodazole experiment) or mitosis (in the   fac-
tor experiment). Together, these results demonstrate that
Cdc48p is required for cells to pass through G1, as well as
mitosis, in the mitotic cell cycle.
To determine if the G1 arrest phenotype of cdc48-td cells
not treated with   factor was also due to failure of Far1p
degradation, we asked whether deletion of the FAR1 gene
could liberate cdc48-td cells from the G1 arrest. CDC48
(wild-type control)/far1  and cdc48-td/far1  strains were
used to perform experiments similar to those shown in Fig.
3 A. As expected, CDC48/far1  cells showed no cell cycle
arrest without nocodazole, and they could be blocked in
G2/M by nocodazole at 37 C (Fig. 3 B). However, unlike
cdc48-td cells with an intact FAR1 that have both G1 and
G2/M arrest points as discussed in the previous paragraph,
most cdc48-td/far1  cells could traverse G1 and only arrest
in G2/M at 37 C with or without nocodazole (Fig. 3 B).
Therefore, deletion of FAR1 allowed cdc48-td cells to bypass
G1 arrest even when Cdc48-td protein was degraded.
In addition to deletion of the FAR1 gene, elimination of the
Far1p-mediated inhibition of Cdc28p-Cln kinase activities
can be achieved by constitutive overexpression of CLN2 (Oeh-
len and Cross, 1994). By using a cdc48-td/GAL-CLN2 strain
in which the chromosomal copy of CLN2 was placed under
the control of a galactose inducible promoter, we tested
whether GAL-CLN2 could also allow cdc48-td cells to traverse
Start at 37 C. Unlike cdc48-td/CLN2 cells, which arrested in
both G1 and G2/M at 37 C (Fig. 3, A and C), cdc48-td/GAL-
CLN2 cells could bypass the G1 block and only arrested in
G2/M at 37 C (Fig. 3 C). Together, the results from Fig. 3
strongly suggest that the essential function of Cdc48p in Start
is achieved through degradation of Far1p, leading to activa-
tion of CLN expression and of the Cdc28p-Cln kinase.
To determine if the action of Cdc48p in Far1p degra-
dation was through binding to Far1p, we performed recip-
rocal coimmunoprecipitation (coIP) experiments between
Cdc48p and Far1p. Cells were first blocked in G1 with  
factor, and then released into fresh medium. Cells, harvested
7–20 min after   factor removal, were pooled for the coIP
experiments. Because Far1p degradation occurs during this
period, possible interactions between Cdc48p and Far1p are
most likely to be detected. Both Far1-Myc and Cdc48p
were detected in the anti-Myc immunoprecipitates from the
FAR1-Myc, but not the untagged control strains (Fig. 4 A).
In the reciprocal coIP, an anti-Cdc48 antiserum also precip-
itated both Cdc48p and Far1-Myc (Fig. 4 B). To confirm
that the smear on the anti-Myc immunoblot after anti-
Cdc48 immunoprecipitation (IP; Fig. 4 B, lane 3) repre-
sented ubiquitinated Far1-Myc, we performed a two-step IP
experiment. First, yeast cell extracts were immunoprecipi-
tated with anti-Cdc48. Next, the precipitated proteins were
dissolved, denatured, and reprecipitated with an anti-Myc
antibody. The precipitated proteins after the two-step IP
were analyzed by immunoblotting using anti-Myc and anti-
ubiquitin antibodies. Far1-Myc and its ubiquitinated forms
were detected in the immunoprecipitates from the FAR1-
Myc, but not the untagged control strains (Fig. 4 C). More-
over, ubiquitinated Far1p was enriched relative to un-ubiq-
uitinated Far1p (Fig. 4 B, compare lane 3 with lane 1; and
Fig. 4 C, compare lane 4 with lane 2), as has been shown for
some other proteolysis substrates (Dai et al., 1998; Rape et
al., 2001). These results suggest that Cdc48p participates in
Far1p degradation by interacting with Far1p.
Figure 4. Cdc48p physically interacts with Far1p and CDC48 
genetically interacts with CDC34. FAR1-Myc (A and C) and FAR1-
untagged (A–C) cells were arrested in G1 with   factor and released 
from the arrest. Cells harvested 7–20 min after release were pooled, 
and yeast cell extracts were immunoprecipitated with anti-Myc (A), 
preimmune serum (B), or anti-Cdc48 (B and C). Anti-Cdc48 immuno-
precipitates in C were dissolved, denatured, and reprecipitated with 
anti-Myc. Immunoprecipitates were analyzed by immunoblotting 
with anti-Myc, anti-Cdc48, or antiubiquitin. (D) Spores of a tetratype 
tetrad from the CDC48 cdc34-1/cdc48-3 CDC34 double hetero-
zygous diploid were incubated at 25, 30, or 37 C. Spore 1, double 
mutant; spores 2 and 4, single mutants; and spore 3, wild type. The 
original single cdc34-1and cdc48-3 mutants were used for comparison. 
(E) A model for the function of Cdc48p in G1 control. See Results 
and discussion for details.T
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Far1p degradation is mediated through the G1 ubiquitin–
conjugating system composed of Cdc34p, Cdc4p, Cdc53p,
and Skp1p (Henchoz et al., 1997; Blondel et al., 2000). We
asked if the function of Cdc48p in Far1p degradation is
through the G1 proteolysis pathway by testing if double mu-
tants in CDC48 and CDC34 had synthetic lethality interac-
tions. Haploid cdc48-3 and cdc34-1 single mutants in the
same strain background were crossed, tetrads analysis was
performed, and the segregants were incubated at 25 C. The
colonies were replica plated and incubated at 25 , 30 , and
37 C to examine the growth of the spores. 19 tetrads were
analyzed and 13 tetratypes, 2 parental ditypes, and 4 nonpa-
rental ditypes were found, nearly matching the expected ra-
dio. Of the 21 cdc48–3 cdc34–1 double mutants, eight failed
to form colonies and arrested growth as microcolonies, each
with roughly 100 cells on tetrad dissection plates at 25 C
(unpublished data). The double mutants that did form small
colonies grew much more slowly than did the cdc48-3 and
cdc34-1 single mutants at 25 C; and unlike the single mu-
tants, the double mutants were nonviable at 30 C (Fig. 4
D). The synthetic growth defects of the cdc48-3 cdc34-1
double mutants are consistent with Cdc48p and Cdc34p be-
ing involved in the same pathway, which is likely to be deg-
radation of Far1p.
The G2/M arrest phenotypes of the previous cdc48-1 mu-
tant had led to the classification of CDC48 as a cell division
cycle gene required for mitosis (Moir et al., 1982; Frohlich
et al., 1991). We have established that Cdc48p is also essen-
tial for activation of the Cdc28-Cln kinase via degradation
of Far1p in G1 phase, and that degradation of Far1p is re-
quired for Start traverse in the normal mitotic cell cycle, as
well as for cell cycle reentry after   factor treatment and sub-
sequent release. Our findings demonstrate new functions of
Cdc48p; i.e., to be a critical G1 regulator through degrada-
tion of Far1p, which is the first CDK inhibitor discovered as
a substrate of Cdc48p-mediated proteolysis. It will be of in-
terest and significance to examine if some other CDK inhib-
itors are also substrates in Cdc48p/p97-mediated proteolysis
pathways in yeast and other eukaryotes.
The functions of Far1p have previously been defined only
in the context of response to mating pheromone. However,
the expression of FAR1 is cell cycle regulated, with a peak at
the M/G1 transition (McKinney et al., 1993), suggesting
that Far1p may play a role in the normal cell cycle. Consis-
tent with this, Far1p was found in a complex with Cdc28p-
Cln in cells not exposed to pheromone, although the
amount of Far1p bound to Cdc28p-Cln increased signifi-
cantly when cells were treated with   factor (Peter et al.,
1993; Gartner et al., 1998). Now, we conclude that efficient
turnover of Far1p is necessary for cell cycle reentry after  
factor withdrawal and for normal cell cycle progression, sug-
gesting that Far1p may play a role in the mitotic cell cycle.
In the presence of   factor, phosphorylation of Far1p by
the pheromone-induced MAP kinase Fus3p inhibits degra-
dation of Far1p, leading to Far1p accumulation and G1 ar-
rest (Peter et al., 1993). We show that if Cdc48p is absent,
as in cdc48-td cells at 37 C, accumulation of Far1p, even in
the absence of   factor, can result in cell cycle arrest in G1.
Therefore, Cdc48p-mediated Far1p degradation is essential
for the mitotic cell cycle. Our findings raise the intriguing
possibility that Far1p may play an important role in the
normal cell cycle; perhaps it ensures genomic stability, a
function attributed to the Cdc28p-Clb inhibitor Sic1p
(Lengronne and Schwob, 2002) and mammalian CDK in-
hibitors, such as p21 and p27, whose loss of function can
lead to genomic instability and cancer. In such a hypothesis
(Fig. 4 E), we propose that yeast cells use Far1p to inhibit
the expression of CLN genes and Cdc28p/Cln kinase activi-
ties in early G1, until the cells are well prepared to commit
to another cell cycle. Far1p is degraded through the ubiq-
uitin–Cdc48p–proteosome proteolysis pathway, and the
cells traverse Start, leading to the G1 to S transition.
Materials and methods
Construction of yeast strains
The cdc48-td strain was generated by inserting a HindIII–MspI CDC48
fragment into the HindIII-ClaI sites of plasmid pPW66R (a gift from J. Diff-
ley, Cancer Research, UK; Dohmen et al., 1994), followed by linearization
within the CDC48 sequence by SphI and integration into the CDC48 chro-
mosomal locus in the YKL83 strain (ubr1 ::GAL-UBR1; Labib et al., 2000).
To construct the CLN2-Myc (with 13 tandem copies of the c-Myc epitope)
strain, a DNA fragment obtained by PCR with the primers OL164 and
OL165, using plasmid pFA6a-13myc-kanMX6 (a gift from B. Stillman,
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY; Longtine et al.,
1998) as the template, was transformed into cdc48-td to generate YL559.
The same strategy was used to generate the FAR1-Myc strain using OL173
and OL174 instead of OL164 and OL165. To generate the GAL-CLN2
strain, the PCR product obtained with primers OL190 and OL191 and
plasmid pFA6a-kanMX6-pGAL1–3HA (a gift from B. Stillman; Longtine et
al., 1998) was introduced into cdc48-td to generate YL571. To generate
the corresponding wild-type control strains, plasmid YEp213-CDC48,
which was constructed by cloning a 3,946-bp MscI fragment containing
CDC48 into YEp213 by blunt end ligation, was transformed into these
cdc48-td strains, generating YL569, YL572, and YL573, respectively. To
construct the far1  strains in CDC48 and cdc48-td backgrounds, PCR
product obtained with primers OL172 and OL173 and plasmid pFA6a-
kanMX6 (a gift from B. Stillman; Longtine et al., 1998) was introduced into
YKL83 and cdc48-td to replace the chromosomal copy of FAR1, generat-
ing YL560 and YL561, respectively.
Sequences of the primers
Primers used for strain construction were as follows: OL164, 5 -agcagtgcc-
tcatctttaatttcttttggtatgggcaatacccaagtaatacggatccccgggttaattaa-3 ;  OL165, 5 -
ttttggtacgtttggcaaattggcattcatttatcatgaaaagaacaggaagaattcgagctcgtttaaac-3 ;
OL172, 5 -gtctatagatccactggaaagcttcgtgggcgtaagaaggcaatctattacggatcccc-
gggttaattaa-3 ; OL173, 5 -aaaggaaaagcaaaagcctcgaaatacgggcctcgattcccg-
aactagaattcgagctcgtttaaac-3 ; OL174, 5 -tggtaaagcagcaaagaattcatcaga-
ccctgaagttcccaacctccggatccccgggttaattaa-3 ;  OL190, 5 -ctctatagctgccaa-
ttcattcgcttaccacatcataatttgcatacagaattcgagctcgtttaaac-3 ; and OL191, 5 -
gatgacgagtcccatacggggtcttggttcagcactagcagccattgtgcactgagcagcgtaatctg-3 .
Cdc28 kinase assay
Soluble cell extracts were prepared by bead beating with lysis buffer (50 mM
Tris-HCl, pH 7.5, 50 mM NaF, 5 mM EDTA, 0.1% NP-40, 250 mM NaCl,
and 1  “Complete Protease Inhibitors” added just before use; Roche). Each
extract (200  g of total proteins) was added to 15  l p13
Suc1-agarose beads
(Upstate Biotechnology) and incubated at 4 C for 2 h to precipitate Cdc28p.
The beads were washed four times with lysis buffer. Proteins bound to half
of the beads were used in immunoblotting to check the precipitation effi-
ciency of Cdc28p. The other half of the beads was washed twice with H1 ki-
nase buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, and 1 mM DTT). Some
10  l of kinase assay mixture (10  Ci  -[
32P] ATP, 2  g histone H1, and 100
 M ATP in 1  kinase buffer) was added to the beads, and the mixture was
incubated at 25 C for 10 min. The reaction was stopped by adding 10  l of
2  Laemmli’s buffer followed by boiling. Samples were resolved by 10%
SDS-PAGE gel and subjected to autoradiography.
Two-step IP
Immunoprecipitates of the first (anti-Cdc48; a gift from K. Frohlich, Physi-
ologisch-chemisches Institut, Tubingen, Germany) IP were boiled in 50  lT
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of lysis/IP buffer (Zhang et al., 2002) containing 1% SDS for 10 min. Next,
solublized proteins were diluted with 450  l of lysis/IP buffer and sub-
jected to the second (anti-Myc) IP.
Cell synchronization, flow cytometry, immunoprecipitation, 
and immunoblotting 
These experiments were performed as described previously (Liang and
Stillman, 1997; Zhang et al., 2002).
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